U.S. Physical Therapy acquires 12-clinic practice, expands to 45 states
U.S. Physical Therapy, Inc. acquired a 67% equity interest in a twelve-clinic practice effective July 1, 2026, expanding its footprint to 45 states. The practice generates 112,000 annual visits and $12 million in annual revenue.

*this image is generated using AI for illustrative purposes only.
U.S. Physical Therapy, Inc. has acquired a 67% equity interest in a twelve-clinic physical therapy practice, expanding its operational footprint to 45 states. The acquisition, effective July 1, 2026, includes a practice that currently generates approximately 112,000 annual visits and $12 million in annual revenue. The remaining 33% equity interest is retained by the current owners.
Strategic Expansion
This transaction marks U.S. Physical Therapy's entry into a new state, increasing its presence from 44 to 45 states. Graham Reeve, Chief Operating Officer-West, stated that the expansion represents an important step in the company's continuing growth. He emphasized that the new partners are known for delivering exceptional clinical care and building trusted relationships within their communities.
Operational Metrics
The acquired practice contributes significant scale to the company's national network. The following table outlines the key operational metrics of the newly acquired entity:
| Metric | Value |
|---|---|
| Clinics Acquired | 12 |
| Annual Visits | 112,000 |
| Annual Revenue | $12 million |
| USPH Equity Interest | 67% |
Company Overview
Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 795 outpatient physical therapy clinics across 45 states. The company provides preventative and post-operative care for orthopedic-related disorders, sports-related injuries, and neurologically related injuries. Additionally, U.S. Physical Therapy operates an industrial injury prevention business offering onsite services such as injury prevention, rehabilitation, and ergonomic assessments.
How will U.S. Physical Therapy integrate the retained 33% equity owners into its operational framework?
Does this acquisition signal a shift in strategy toward entering new geographic markets rather than consolidating existing ones?
What are the projected financial synergies and cost savings from scaling this twelve-clinic practice?

























